Change in access to prescribed medication following an episode of deliberate self-poisoning: A multilevel approach

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Gjelsvik, Bergljot ^a   Heyerdah, Fridtjof ^b   Lunn, Daniel ^c   Hawton, Keith ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PRESCRIPTION DRUG; PSYCHOTROPIC AGENT;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; HEALTH CARE ACCESS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NORWAY; OUTCOME ASSESSMENT; PRESCRIPTION; SELF POISONING; SEX DIFFERENCE; DRUG MISUSE; INTOXICATION; REGISTER; SUICIDE ATTEMPT;

HUMANS; NORWAY; POISONING; PRESCRIPTION DRUG MISUSE; REGISTRIES; SUICIDE, ATTEMPTED;

EID: 84901364279     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098086     Document Type: Article

References (20)

1. Prescott K, Stratton R, Freyer A, Hall I, Le Jeune I (2009) Detailed analyses of self-poisoning episodes presenting to a large regional teaching hospital in the UK. Br J Clin Pharmacol 68:260-268
2. Gjelsvik B, Heyerdahl F, Hawton K (2012) Prescribed medication availability and deliberate self-poisoning: a longitudinal study. J Clin Psychiatry 73: e548-554.
3. Gjelsvik B, Heyerdahl F, Hawton K (2013) Deliberate self-poisoning with prescribed drugs is not related to medical severity of acts. J Clin Psychiatry 74:630.
4. Bergen H, Hawton K, Waters K, Ness J, Cooper J, et al. (2012) Premature death after self-harm: a multicentre cohort study. Lancet 380:1568-1574.
5. Bjornaas MA, Jacobsen D, Haldorsen T, Ekeberg O (2009) Mortality and causes of death after hospital-treated self-poisoning in Oslo: a 20-year follow-up. Clin Toxicol 47:116-123.
6. De Leo D, Scocco P, Marietta P, Schmidtke A, Bille-Brahe U, et al. (1999) Physical illness and parasuicide: evidence from the European Parasuicide Study Interview Schedule (EPSIS/WHO-EURO). Int J Psychiatry Med 29:149-163.
7. Hawton K, Harriss L, Zahl D (2006) Deaths from all causes in a long-term follow-up study of 11,583 deliberate self-harm patients. Psychol Med 36:397-405.
8. Deisenhammer EA, Ing CM, Strauss R, Kemmler G, Hinterhuber H, et al. (2009). The duration of the suicidal process: how much time is left for intervention between consideration and accomplishment of a suicide attempt? J Clin Psychiatry 70: 19-24.
9. Gvion Y, Apter A (2011) Aggression, impulsivity, and suicide behavior: A review of the literature. Arch Suicide Res 15: 93-112.
10. Hawton K, Harriss L, Hall S, Simkin S, Bale E, et al. (2003) Deliberate selfharm in Oxford, 1990-2000: a time of change in patient characteristics. Psychol Med 33: 987-995. (Pubitemid 37009817)
11. International language for drug utilization research (2013) http://www.whocc.no.
12. Hoiseth G, Bramness JG, Christophersen AS, Morland J (2007) Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003. Int J Legal Med 121:403-9. (Pubitemid 47300302)
13. Furlanetto LM, Mendlowicz MV, Romildo Bueno J (2005) The validity of the Beck Depression Inventory-Short Form as a screening and diagnostic instrument for moderate and severe depression in medical inpatients. J Affect Disord 86: 87-91. (Pubitemid 40487964)
14. Tang NK, Crane C (2006) Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links. Psychol Med 36:575-586.
15. Hovstadius B, Petersson G (2012) Factors Leading to Excessive Polypharmacy. Clin Geriatr Med 28:159-172.
16. Neutel CI, Skurtveit S, Berg C (2012) Polypharmacy of potentially addictive medication in the older persons-quantifying usage. Pharmacoepidem Dr S 21:199-206.
17. Neutel CI, Skurtveit S, Berg C (2012) Dramatic Increases in the Use of Strong Opioids in the Elderly. Pharmacoepidem Dr S 21: 172-173.
18. Kjosavik SR, Ruths S, Hunskaar S (2009) Psychotropic drug use in the Norwegian general population in 2005: data from the Norwegian Prescription Database. Pharmacoepidem Dr S 18:572-578.
19. Hawton K (2005) Restriction of access to methods of suicide as a means of suicide prevention. In: Hawton K (ed) Prevention and treatment of suicidal behavior: from science to practice, Oxford University Press: Oxford, pp 279-292.
20. National Institute for Health and Clinical Excellence (2011) Self-harm: longer-term management. Clinical Guideline CG133; Available from: http://guidance.nice.org.uk/CG133.